DAA2045 |
Loss of muscle torque |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA642 |
Muscle atrophy (sarcopenia) |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA2026 |
Mutations in mitochondrial DNA accumulate |
Physiological |
heart, kidney, skeletal muscle, cerebral cortex, cerebellum |
Human |
— |
— |
|
DAA2040 |
Reduced type II muscle fiber |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA643 |
Muscle fiber energy metabolism declines |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA2057 |
MicroRNA let-7e expression upregulated |
Molecular |
skeletal muscle |
Human |
— |
— |
|
DAA1992 |
Muscle mass and strength loss |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA1940 |
Grip strength decreases |
Physiological |
skeletal muscle |
Mouse |
— |
— |
|
DAA2056 |
MicroRNA let-7b expression upregulated |
Molecular |
skeletal muscle |
Human |
— |
— |
|
DAA2599 |
Telomere shortening |
Physiological |
adipose tissue, skeletal muscle, skin, leukocyte |
Human |
— |
— |
|
DAA1891 |
zinc finger, ZZ domain containing 3 |
Molecular |
skeletal muscle |
Mouse |
Zzz3 |
12.0% Decrease Gene Expression Level |
|
DAA513 |
zinc finger, FYVE domain containing 20 |
Molecular |
skeletal muscle |
Human |
ZFYVE20 |
3.0% Increase Gene Expression Level |
|
DAA1890 |
zinc finger protein 651 |
Molecular |
skeletal muscle |
Mouse |
Zfp651 |
7.0% Increase Gene Expression Level |
|
DAA388 |
zinc finger protein 36, C3H type-like 1 |
Molecular |
skeletal muscle |
Human |
ZFP36L1 |
6.0% Increase Gene Expression Level |
|
DAA330 |
zinc finger and BTB domain containing 4 |
Molecular |
skeletal muscle |
Human |
ZBTB4 |
2.0% Increase Gene Expression Level |
|
DAA554 |
exportin 6 |
Molecular |
skeletal muscle |
Human |
XPO6 |
3.0% Increase Gene Expression Level |
|
DAA353 |
xeroderma pigmentosum, complementation group C |
Molecular |
skeletal muscle |
Human |
XPC |
7.0% Increase Gene Expression Level |
|
DAA586 |
xeroderma pigmentosum, complementation group C |
Molecular |
skeletal muscle |
Human |
XPC |
6.0% Increase Gene Expression Level |
|
DAA1853 |
X-linked inhibitor of apoptosis |
Molecular |
skeletal muscle |
Mouse |
Xiap |
13.0% Decrease Gene Expression Level |
|
DAA436 |
WD repeat domain 12 |
Molecular |
skeletal muscle |
Human |
WDR12 |
3.0% Decrease Gene Expression Level |
|
DAA565 |
vesicle transport through interaction with t-SNAREs homolog 1B (yeast) |
Molecular |
skeletal muscle |
Human |
VTI1B |
3.0% Decrease Gene Expression Level |
|
DAA384 |
vacuolar protein sorting 13 homolog C (S. cerevisiae) |
Molecular |
skeletal muscle |
Human |
VPS13C |
3.0% Increase Gene Expression Level |
|
DAA517 |
very low density lipoprotein receptor |
Molecular |
skeletal muscle |
Human |
VLDLR |
4.0% Decrease Gene Expression Level |
|
DAA423 |
vascular endothelial growth factor B |
Molecular |
skeletal muscle |
Human |
VEGFB |
6.0% Decrease Gene Expression Level |
|
DAA375 |
ubiquitin specific peptidase 6 (Tre-2 oncogene) |
Molecular |
skeletal muscle |
Human |
USP6 |
5.0% Increase Gene Expression Level |
|